methamphetamine has been researched along with Atrophy in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Chang, L; Cunningham, E; Ernst, TM; Liang, HJ; Nakama, H; Wang, HA | 1 |
Alikhani, M; Brand, S; Farnia, V; Farshchian, F; Farshchian, N; Sadeghi Bahmani, D | 1 |
Hasnan, J; Islam, MN; Jesmine, K; Kong Sn Molh, A | 1 |
Chang, L; Cloak, CC; Ernst, T; Fujii, L; Hedemark, B | 1 |
Abe, H; Harano, M; Iida, N; Inada, T; Ishibashi, M; Iyo, M; Komiyama, T; Maeda, H; Ozaki, N; Sekine, Y; Sora, I; Tanaka, T; Uchimura, N; Ujike, H; Yamada, M; Yanagimoto, K | 1 |
Archibald, SL; Ellis, RJ; Fennema-Notestine, C; Gamst, AC; Grant, I; Heaton, RK; Jernigan, TL; Marcotte, TD; Marcotte, TL; Mindt, MR | 1 |
Berman, SM; Brody, AL; Geaga, JA; Hayashi, KM; Hong, MS; Ling, W; London, ED; Mandelkern, MA; Monterosso, J; Rawson, RA; Simon, SL; Thompson, PM; Voytek, B | 1 |
Fang, HC; Higgins, RE; Mestek, MF; Rumbaugh, CL; Wilson, GH | 1 |
McGlothlin, WH | 1 |
1 review(s) available for methamphetamine and Atrophy
Article | Year |
---|---|
Drug use and abuse.
Topics: Atrophy; Barbiturates; Brain; Cannabis; Dose-Response Relationship, Drug; Efficiency; Hallucinogens; Humans; Immunity, Cellular; Methadone; Methamphetamine; Narcotic Antagonists; Opium; Substance-Related Disorders; Therapeutic Community; United States | 1975 |
8 other study(ies) available for methamphetamine and Atrophy
Article | Year |
---|---|
Independent and combined effects of methamphetamine use disorders and APOEε4 allele on cognitive performance and brain morphometry.
Topics: Alleles; Apolipoprotein E4; Atrophy; Brain; Cognition; Genotype; Humans; Magnetic Resonance Imaging; Methamphetamine; Neuropsychological Tests | 2023 |
Comparisons of Voxel-Based Morphometric Brain Volumes of Individuals with Methamphetamine-Induced Psychotic Disorder and Schizophrenia Spectrum Disorder and Healthy Controls.
Topics: Adult; Amygdala; Atrophy; Central Nervous System Stimulants; Female; Gray Matter; Hippocampus; Humans; Limbic System; Male; Methamphetamine; Parahippocampal Gyrus; Psychoses, Substance-Induced; Putamen; Schizophrenia; White Matter; Young Adult | 2020 |
Histopathological studies of cardiac lesions after long term administration of methamphetamine in high dosage--Part II.
Topics: Animals; Atrophy; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; Eosinophils; Fibrosis; Forensic Pathology; Forensic Toxicology; Granulation Tissue; Heart; Hypertrophy; Injections, Intraperitoneal; Male; Methamphetamine; Microscopy; Myocardium; Rats; Rats, Wistar; Vacuoles | 2009 |
Lower diffusion in white matter of children with prenatal methamphetamine exposure.
Topics: Abnormalities, Drug-Induced; Anisotropy; Atrophy; Brain; Central Nervous System Stimulants; Child, Preschool; Cognition Disorders; Corpus Callosum; Dendritic Spines; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Humans; Intelligence; Male; Methamphetamine; Nerve Fibers, Myelinated; Neuropsychological Tests; Pregnancy; Prenatal Exposure Delayed Effects; Wallerian Degeneration | 2009 |
A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosis.
Topics: Adult; Atrophy; Brain; Genotype; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Psychoses, Substance-Induced; Receptors, Dopamine D2 | 2004 |
Effects of methamphetamine dependence and HIV infection on cerebral morphology.
Topics: Adult; Age Factors; Animals; Atrophy; Brain; Brain Mapping; Cerebral Cortex; Cognition Disorders; Comorbidity; Female; HIV Infections; Humans; Hypertrophy; Magnetic Resonance Imaging; Male; Methamphetamine; Neuropsychological Tests; Substance-Related Disorders | 2005 |
Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers.
Topics: Adult; Arousal; Atrophy; Brain; Brain Mapping; Central Nervous System Stimulants; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methamphetamine; Neuropsychological Tests; Positron-Emission Tomography; Substance Withdrawal Syndrome; Substance-Related Disorders | 2005 |
Cerebral CT findings in drug abuse: clinical and experimental observations.
Topics: Administration, Oral; Adolescent; Adult; Animals; Atrophy; Brain; Cannabis; Cerebral Ventricles; Dilatation, Pathologic; Haplorhini; Humans; Injections, Intravenous; Macaca mulatta; Male; Methamphetamine; Secobarbital; Substance-Related Disorders; Tomography, X-Ray Computed | 1980 |